That 71-pound weight loss happened over 68 weeks in a monitored clinical trial, not in a 10-second reel. If you have PCOS, the drug promising your transformation was never tested on your hormones.

A client sitting at 221 pounds with PCOS since age 18 wanted retatrutide to lose weight fast before freezing her eggs. This episode breaks down what triple-receptor agonists actually do inside your body, why the trial numbers ignore hormonal imbalances entirely, and how she lost 9 pounds in phase one without ever touching the drug.

In this episode:

• Why PCOS hunger is leptin resistance, a hormonal issue, not a willpower problem retatrutide can permanently fix
• How retatrutide activates three receptors: GLP-1 for fullness, GIP for insulin sensitivity, glucagon to burn liver fat
• The phase three 71-pound result came over 68 weeks in a monitored trial, not the highlight reel you scroll past
• Are you seeing the full picture, or only survivorship bias where failed cases never become transformation reels?
• Why zero clinical studies exist on retatrutide in PCOS cases, and it is not even FDA approved
• How GLP-1 studies show most patients regain two-thirds of lost weight, plus muscle loss that lowers your BMR
• What egg freezing demands metabolically, and how folate, iron, and omega-3 supported her eggs instead
• The two-phase plan: make the body feel safe first, drop HIIT for low-impact home workouts, then lose 9 pounds naturally

🎥 Watch the video version on YouTube

Follow the show so you never miss an episode.

This episode is educational and isn't medical advice. For decisions about your labs or treatment, talk to your clinician.